Clinical Trials in Boston

Showing 8821-8840 of 13,548 trials

A Community-based Study to Target Childhood Obesity

NCT02890056

The purpose of this study is to determine the efficacy of a community-based behavioral intervention (H2GO!) on decreasing sugar-sweetened beverage consumption and promoting water consumption among school-aged youth and parents/caregivers. We hypothesize that participants in the intervention site will demonstrate reduced sugar-sweetened beverage intake intake and increased water intake compared to participants in the comparison site at 2 and 6 months follow-up.

Obesity

Boston University207 participantsStarted Sep 2016

Boston, Massachusetts, United States

COMPLETEDPhase 2< 1 mile

TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma

NCT02396511

The purpose of this study is to determine whether TRC105 in combination with Bevacizumab is effective in the treatment of two patients with metastatic and refractory choriocarcinoma.

Choriocarcinoma

Tracon Pharmaceuticals Inc.2 participantsStarted Jan 2015

Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

Personal Web Page In Clinical Trial Participant Education

NCT03887091

This research study is evaluating the effectiveness of video and web-based communication in clinical research compared to standard practices.

Prostate CancerKidney CancerGenitourinary Cancer

Dana-Farber Cancer Institute99 participantsStarted Jul 2014

Boston, Massachusetts, United States

COMPLETED< 1 mile

Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry

NCT02239640

The purpose of this registry is to assess clinical outcomes, and different factors that may affect these clinical outcomes such as systems of care, associated with the use of Covidien market-released neurothrombectomy devices intended to restore blood flow in patients experiencing acute ischemic stroke due to large intracranial vessel occlusion.

Ischemic Stroke

Medtronic Neurovascular Clinical Affairs984 participantsStarted Aug 2014

Phoenix, Arizona, United States • Tucson, Arizona, United States • Irvine, California, United States +52 more locations

A Community-based Study to Target Childhood Obesity

TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma

Personal Web Page In Clinical Trial Participant Education

Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke (STRATIS) Registry

Find Trials by Condition in Boston

Function and Form Outcomes in Patients With Facial Paralysis

Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant

FITT Exercise Counseling With Interactive Accelerometry and Physical Activity in Adolescents at Increased Risk of Early Cardiovascular Disease: A Pilot Study

The Plecanatide Chronic Idiopathic Constipation (CIC) Study

Tele-Pharmacy Intervention to Improve Treatment Adherence

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator

Integrated Chronotherapy for Perinatal Depression

A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency

BKM120 as Second-line Therapy for Advanced Endometrial Cancer

Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold

STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer